Logo image of AVTX

AVALO THERAPEUTICS INC (AVTX) Stock News

NASDAQ:AVTX - Nasdaq - US05338F3064 - Common Stock - Currency: USD

3.75  -0.16 (-4.09%)

AVTX Latest News, Press Relases and Analysis

News Image
13 days ago - Avalo Therapeutics

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected...

News Image
25 days ago - Avalo Therapeutics

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused...

News Image
10 months ago - BusinessInsider

AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avalo Therapeutics (NASDAQ:AVTX) just reported results for the second quarter o...

News Image
10 months ago - InvestorPlace

AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024

AVTX stock results show that Avalo Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

News Image
2 months ago - Avalo Therapeutics

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

WAYNE, Pa. and ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company...

News Image
2 months ago - Avalo Therapeutics

Avalo Reports 2024 Financial Results and Recent Business Updates

Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as Chief Strategy...

News Image
4 months ago - Avalo Therapeutics

Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

WAYNE, Pa. and ROCKVILLE, Md. , Feb. 04, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused...

News Image
5 months ago - Avalo Therapeutics

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused...

News Image
6 months ago - Avalo Therapeutics

Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants

Proceeds from the full exercise of warrants issued in the first quarter of 2024 private placement bring the total gross proceeds from the transaction to...

News Image
7 months ago - Avalo Therapeutics

Avalo Therapeutics to Present at Upcoming Investor Conferences

WAYNE, Pa. and ROCKVILLE, Md., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused...

News Image
7 months ago - Avalo Therapeutics

Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates

Dosed first patient in Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa (HS), with topline data expected in 2026Cash position...

News Image
8 months ago - Avalo Therapeutics

Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of AVTX-009 compared to...

News Image
10 months ago - Avalo Therapeutics

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Expects to enroll first patient in Phase 2 LOTUS Trial of AVTX-009 in hidradenitis suppurativa in the second half of 2024Appointed Dr. Mittie Doyle as...

News Image
10 months ago - InvestorPlace

The 3 Best Personalized Nutrition Stocks to Buy Now

Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.

Mentions: ME VCYT

News Image
10 months ago - Avalo Therapeutics

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has...

News Image
a year ago - Avalo Therapeutics

Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa

Following FDA review, Avalo’s IND application for AVTX-009 is active allowing Avalo to proceed with its Phase 2 trial (LOTUS) to evaluate the efficacy and...

News Image
a year ago - Avalo Therapeutics

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the...